Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
B.R.A.I.N. Biotechnology Research and Information Network (GB:0RFI)
:0RFI
0RFI Stock Chart & Stats
Day’s Range― - ―
52-Week Range€1.47 - €4.47
Previous CloseN/A
Volume57.99K
Average Volume (3M)66.00
Market Cap
€61.17M
Enterprise Value€50.18M
Total Cash (Recent Filing)N/A
Total Debt (Recent Filing)N/A
Price to Earnings (P/E)―
Beta0.31
Next Earnings
Feb 26, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.51
Shares Outstanding21,847,494
10 Day Avg. Volume41
30 Day Avg. Volume66
Standard Deviation0.18
R-Squared0.11
Alpha-0.00536
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)2.52
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€7.00Price Target Upside147.35% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
---
0RFI FAQ
What was B.R.A.I.N. Biotechnology Research and Information Network’s price range in the past 12 months?
B.R.A.I.N. Biotechnology Research and Information Network lowest share price was €1.47 and its highest was €4.47 in the past 12 months.
What is B.R.A.I.N. Biotechnology Research and Information Network’s market cap?
B.R.A.I.N. Biotechnology Research and Information Network’s market cap is €61.17M.
When is B.R.A.I.N. Biotechnology Research and Information Network’s upcoming earnings report date?
B.R.A.I.N. Biotechnology Research and Information Network’s upcoming earnings report date is Feb 26, 2025 which is in 4 days.
How were B.R.A.I.N. Biotechnology Research and Information Network’s earnings last quarter?
B.R.A.I.N. Biotechnology Research and Information Network released its earnings results on Jan 15, 2025. The company reported -€0.3 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.3.
Is B.R.A.I.N. Biotechnology Research and Information Network overvalued?
According to Wall Street analysts B.R.A.I.N. Biotechnology Research and Information Network’s price is currently Undervalued.
Does B.R.A.I.N. Biotechnology Research and Information Network pay dividends?
B.R.A.I.N. Biotechnology Research and Information Network does not currently pay dividends.
What is B.R.A.I.N. Biotechnology Research and Information Network’s EPS estimate?
B.R.A.I.N. Biotechnology Research and Information Network’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does B.R.A.I.N. Biotechnology Research and Information Network have?
B.R.A.I.N. Biotechnology Research and Information Network has 21,847,494 shares outstanding.
What happened to B.R.A.I.N. Biotechnology Research and Information Network’s price movement after its last earnings report?
B.R.A.I.N. Biotechnology Research and Information Network reported an EPS of -€0.3 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -2.279%.
Which hedge fund is a major shareholder of B.R.A.I.N. Biotechnology Research and Information Network?
Currently, no hedge funds are holding shares in GB:0RFI
---
B.R.A.I.N. Biotechnology Research and Information Network Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
€7.00 (147.35% Upside)
€7.00 (147.35% Upside)
Insider Transactions
Bought Shares
Worth €35.8K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 59%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-27.52%
12-Months-Change
Fundamentals
Return on Equity
-64.72%
Trailing 12-Months
Asset Growth
25.09%
Trailing 12-Months
Company Description
B.R.A.I.N. Biotechnology Research and Information Network
Brain Biotechnology Research and Information Network AG is a technology company in the field of industrial biotechnology. It serves the chemical and consumer goods industries. The company develops novel biological ingredients such as enzymes, biocatalysts, and bioactive natural compounds. Its operating segments is BioScience segment and BioIndustrial segment. Generating a majority of its revenue from the BioIndustrial segment.
---
0RFI Stock 12 Month Forecast
Average Price Target
€7.00
▲(147.35% Upside)
Technical Analysis
Best Analysts Covering 0RFI
1 Year
1 Year Success Rate
2/3 ratings generated profit
1 Year Average Return
+35.03%
reiterated a buy rating last month
Copying Nicolas Pauillac's trades and holding each position for 1 Year would result in 66.67% of your transactions generating a profit, with an average return of +35.03% per trade.
---